Skip to main content
Premium Trial:

Request an Annual Quote

Rockefeller University Grants Rosetta Genomics Rights to Study Its microRNAs

NEW YORK (GenomeWeb News) - Rosetta Genomics has licensed from Rockefeller University the right to access nearly 180 of its microRNAs, Rosetta said today.
Rosetta said it will add these microRNAs to its existing microRNA database, which could arm it with additional biomarker candidates for its diagnostic development programs.
Rosetta has discovered nearly 360 biologically validated human microRNAs and the Rockefeller agreement will enable it to study 530 of the 660 publicly confirmed microRNA genes in the entire human genome, the company said.
The company will use the microRNAs to "potentially advance multiple" research development programs targeting new microRNA-based diagnostic tools for a "variety" of diseases.
Terms of the agreement call for Rosetta Genomics to pay Rockefeller University an initiation fee as well as maintenance fees and royalties.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.